Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit

Hedge fund BVF reported a full exit from Protagonist Therapeutics (NASDAQ:PTGX) in its February 17, 2026, SEC filing, selling 2,560,916 shares worth an estimated $170.12 million. What happened According to its SEC filing dated February 17, 2026, BVF fully liquidated its stake in Protagonist Therapeutics (NASDAQ:PTGX), selling 2,560,916 shares. The quarter-end position value decreased by $170.12 million. What else to know BVF sold out of Protagonist Therapeutics. Top holdings after the filing: NASD ...